关注
Ting-Yu Wei
Ting-Yu Wei
Harvard Medical School
在 hms.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Mutant IDH inhibits IFNγ–TET2 signaling to promote immunoevasion and tumor maintenance in cholangiocarcinoma
MJ Wu, L Shi, J Dubrot, J Merritt, V Vijay, TY Wei, E Kessler, KE Olander, ...
Cancer Discovery 12 (3), 812-835, 2022
972022
Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathway
J Zhang, CM Simpson, J Berner, HB Chong, J Fang, Z Ordulu, ...
Cell 186 (11), 2361-2379. e25, 2023
792023
NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer
T Weiss-Sadan, M Ge, M Hayashi, M Gohar, CH Yao, A de Groot, S Harry, ...
Cell metabolism 35 (3), 487-503. e7, 2023
762023
Metabolomics investigation of voriconazole-induced hepatotoxicity in mice
SL Wu, TY Wei, SW Lin, KY Su, CH Kuo
Chemical research in toxicology 32 (9), 1840-1849, 2019
192019
SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers
L Shi, W Shen, MI Davis, K Kong, P Vu, SK Saha, R Adil, J Kreuzer, ...
Nature Cancer 4 (3), 365-381, 2023
132023
系统目前无法执行此操作,请稍后再试。
文章 1–5